Lymphedema Diagnostics Market by Technology (Lymphoscintigraphy, MRI, Near IR Fluorescence Imaging, Ultrasound), Disease Type (Cancer, Inflammatory Diseases, Cardiovascular, Filariasis), End User (Hospitals, Diagnostic Centers) - Global Forecasts to 2024

リンパ浮腫診断の世界市場予測:リンシンシングラフィ、MRI、近赤外蛍光イメージング、超音波

◆タイトル:Lymphedema Diagnostics Market by Technology (Lymphoscintigraphy, MRI, Near IR Fluorescence Imaging, Ultrasound), Disease Type (Cancer, Inflammatory Diseases, Cardiovascular, Filariasis), End User (Hospitals, Diagnostic Centers) - Global Forecasts to 2024
◆商品コード:MD7408
◆調査・発行会社:MarketsandMarkets
◆発行日:2019年10月30日
◆ページ数:166
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥615,850見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥724,850見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥888,350見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社は、リンパ浮腫診断の世界市場規模が2019年24百万ドルから2024年35百万ドルまで年平均7.4%成長すると予測しています。当調査レポートでは、リンパ浮腫診断の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、技術別(リンシンシングラフィ、MRI、近赤外蛍光イメージング、超音波)分析、疾患種類別(がん、炎症性疾患、心血管、フィラリア症)分析、エンドユーザー別(病院、診断センター)分析、リンパ浮腫診断の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“The lymphedema diagnostics market is projected to grow at a CAGR of 7.4% during the forecast period.”The global lymphedema diagnostics market is projected to reach USD 35 million by 2024 from USD 24 million in 2019, at a CAGR of 7.4%. The major factors driving the growth of this market include the increasing global prevalence of cancer and lymphedema; technological advancements in diagnostic imaging modalities; and increasing investments, funds, and grants by public-private organizations. However, the high cost of diagnostic imaging systems, the short half-life of radiopharmaceuticals, and the limited supply of helium are expected to hinder the growth of this market.

“The lymphoscintigraphy segment accounted for the largest market share in 2018.”
Based on technology, the lymphedema diagnostics market is segmented into lymphoscintigraphy, magnetic resonance imaging (MRI), ultrasound imaging, computed tomography (CT), X-ray lymphography, bioimpedance analysis, and near-infrared fluorescence imaging. The lymphoscintigraphy segment accounted for the largest share of the lymphedema diagnostics market in 2018. The noninvasive nature and easy reproducibility of this technology, and the fact that lymphoscintigraphy does not adversely affect the lymphatic vascular endothelium are some of the key advantages supporting the adoption of this technology.

“The cancer segment accounted for the largest share of the lymphedema diagnostics market in 2018.”
On the basis of disease type, the lymphedema diagnostics market is segmented into cancer, inflammatory diseases, cardiovascular disease, and other diseases (congenital abnormalities, trauma-related conditions, infections, and filariasis). The cancer segment accounted for the largest share of the lymphedema diagnostics market in 2018. The large share of this segment can be attributed to the rising prevalence of cancer-associated lymphedema and increasing awareness about early disease diagnosis.

“Europe to account for the second-largest share of the global market in 2019.”
The lymphedema diagnostics market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World. Europe is expected to account for the second-largest share of the global lymphedema diagnostics market in 2019. The rising incidence of chronic diseases and injuries, growing demand for early diagnosis and treatment, technological advancements, product launches, and increasing government and public-private investments for developing novel diagnostic imaging modalities are the major factors driving market growth in Europe.

Breakdown of supply-side primary interviews:
• By Company Type: Tier 1 (25%), Tier 2 (30%), and Tier 3 (42%)
• By Designation: C-level (26%), Director-level (30%), and Others (44%)
• By Region: North America (34%), Europe (26%), APAC (23%), and RoW (17%)

The major players in the market include GE Healthcare (US), Philips (Netherlands), Siemens Healthineers (Germany), Canon, Inc. (Japan), Shimadzu Corporation (Japan), Stryker Corporation (US), Fluoptics (France), United Imaging Healthcare Co., Ltd. (China), Hitachi, Ltd. (Japan), Esaote, SpA (Italy), Neusoft Corporation (China), Mindray Medical International, Ltd. (China), Mitaka USA, Inc. (US), Curadel, LLC (US), and ImpediMed Ltd. (Australia).

Research Coverage
This report studies the lymphedema diagnostics market based on technology, disease type, end user, and region. The report also studies factors (such as drivers and restraints) affecting market growth. In addition, it analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions (and the respective countries in these regions).

Key Benefits of Buying the Report
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, opportunities, and challenges.

【レポートの目次】

1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders
2 Research Methodology (Page No. – 19)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Product-Based Market Estimation
2.2.2 Primary Research Validation
2.3 Market Breakdown and Data Triangulation
2.4 Research Limitations and Assumptions
2.4.1 Limitations
2.4.2 Assumptions
3 Executive Summary (Page No. – 29)
4 Premium Insights (Page No. – 33)
4.1 Lymphedema Diagnostics: Market Overview
4.2 Regional Analysis: Market, By Disease Type (2019)
4.3 Market, By Technology, 2019 vs 2024 (USD Million)
4.4 Near-Infrared Fluorescence Imaging Market, By Type, 2019 vs 2024 (USD Million)
4.5 Market, By Country
5 Market Overview (Page No. – 38)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Global Prevalence of Lymphedema
5.2.1.2 Growing Global Prevalence of Cancer
5.2.1.3 Technological Advancements and Adoption of Newer Diagnostic Modalities
5.2.1.4 Increasing Investments, Funds, and Grants By Public-Private Organizations
5.2.2 Restraints
5.2.2.1 High Cost of Diagnostic Imaging Systems
5.2.2.2 Short Half-Life of Radiopharmaceuticals
5.2.2.3 Limited Supply of Helium
5.2.2.4 Increasing Adoption of Refurbished Diagnostic Imaging Systems
5.2.3 Opportunities
5.2.3.1 Emerging Countries
5.2.4 Challenges
5.2.4.1 Hospital Budget Cuts
6 Lymphedema Diagnostics Market, By Technology (Page No. – 45)
6.1 Introduction
6.2 Lymphoscintigraphy
6.2.1 Lymphoscintigraphy is Rapidly Developing to Be the First-Line Imaging Modality for Lymphedema Diagnostics
6.3 Magnetic Resonance Imaging
6.3.1 Magnetic Resonance Imaging Finds Major Applications in Lymphedema Treatment Planning
6.4 Ultrasound Imaging
6.4.1 Ultrasound Imaging has the Potential to Determine Tissue Changes Consistent With Different Stages of Lymphedema
6.5 Computed Tomography
6.5.1 High Cost of Computed Tomography to Limit Market Growth
6.6 X-Ray Lymphography
6.6.1 Invasive Nature & Risk of Radiation Exposure are Expected to Hamper Market Growth
6.7 Bioimpedance Analysis
6.7.1 Lack of Awareness About Bioimpedance Analysis is Limiting the Growth of This Segment
6.8 Near-Infrared Fluorescence Imaging
6.8.1 ICG Lymphography
6.8.1.1 ICG Lymphography Offers A Powerful Tool for Efficiently Diagnosing Various Stages of Lymphedema
6.8.2 Fluorescein Sodium Microlymphangiography
6.8.2.1 Fluorescein Sodium Microlymphangiography is Limited to Visualizing Only Initial Capillaries
7 Lymphedema Diagnostics Market, By Disease Type (Page No. – 59)
7.1 Introduction
7.2 Cancer
7.2.1 One in Three Cancer-Treated Patients Develop Lymphedema
7.3 Inflammatory Diseases
7.3.1 Growing Prevalence of Inflammatory Conditions to Drive Market Growth
7.4 Cardiovascular Disease
7.4.1 Growing Awareness About Early Disease Diagnosis to Drive the Adoption of Lymphedema Diagnostic Tools
7.5 Other Diseases
8 Lymphedema Diagnostics Market, By End User (Page No. – 64)
8.1 Introduction
8.2 Hospitals
8.2.1 The Large Number of Lymphedema Diagnostic Procedures Performed in Hospitals to Drive Market Growth
8.3 Diagnostic Centers
8.3.1 Increasing Number of Private Imaging Centers to Support Market Growth
8.4 Research & Academic Institutes
8.4.1 Budgetary Restrictions of Researchers are Limiting the Adoption of High-End Lymphedema Diagnostic Technologies
8.5 Other End Users
9 Lymphedema Diagnostics Market, By Region (Page No. – 69)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 The US Dominated the North American Market in 2018
9.2.2 Canada
9.2.2.1 Dearth of Radiologists is Restricting Market Growth in Canada
9.3 Europe
9.3.1 Germany
9.3.1.1 Germany Accounts for the Largest Share of the European Market
9.3.2 France
9.3.2.1 Uncertainties With Regard to the Pricing Strategy of Diagnostic Companies to Limit Market Growth in France to A Certain Extent
9.3.3 UK
9.3.3.1 Rising Diagnostic Imaging Procedural Volumes Indicate Strong Growth in the UK Market
9.3.4 RoE
9.4 Asia Pacific
9.4.1 China
9.4.1.1 Rising Disease Incidence, Increasing Procedural Volumes, and Growth in the Geriatric Population have Contributed to Market Growth in China
9.4.2 Japan
9.4.2.1 Japan’s Well-Established and Well-Equipped Healthcare System Ensures Demand for and Easy Access to Diagnostic Imaging
9.4.3 India
9.4.3.1 Growing Incidence of Lymphatic Filariasis is A Key Contributor to Market Growth
9.4.4 RoAPAC
9.5 Rest of the World
9.5.1 Latin America
9.5.1.1 Latin America Holds the Largest Share of the RoW Market
9.5.2 Middle East & Africa
9.5.2.1 Growing Geriatric Population & Disease Prevalence are Driving Growth in Mea
10 Competitive Landscape (Page No. – 106)
10.1 Introduction
10.2 Ranking of Players, 2018
10.3 Competitive Scenario
10.4 Vendor Dive Overview
10.5 Vendor Inclusion Criteria
10.6 Vendor Dive
10.6.1 Visionary Leaders
10.6.2 Innovators
10.6.3 Dynamic Differentiators
10.6.4 Emerging Companies
11 Company Profiles (Page No. – 111)
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 GE Healthcare
11.2 Siemens Healthineers (A Subsidiary of Siemens Group)
11.3 Philips
11.4 Canon, Inc.
11.5 Shimadzu Corporation
11.6 Stryker Corporation
11.7 Fluoptics
11.8 United Imaging Healthcare Co., Ltd.
11.9 Hitachi, Ltd.
11.10 Esaote SPA
11.11 Neusoft Corporation
11.12 Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.)
11.13 Mitaka Usa, Inc.
11.14 Curadel, LLC
11.15 Impedimed Limited
11.16 Other Companies
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.
12 Appendix (Page No. – 158)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details

List of Tables (107 Tables)
Table 1 Technological Advancements in Diagnostic Imaging Systems
Table 2 Key Investments By Government Bodies in the Diagnostic Imaging Market
Table 3 Lymphedema Diagnostics Market, By Technology, 2017–2024 (USD Million)
Table 4 Comparison of Diagnostic Imaging Tests for Lymphedema
Table 5 Lymphoscintigraphy Market, By Region, 2017–2024 (USD Million)
Table 6 Lymphoscintigraphy Market, By Country, 2017–2024 (USD Million)
Table 7 Magnetic Resonance Imaging Market, By Region, 2017–2024 (USD Million)
Table 8 Magnetic Resonance Imaging Market, By Country, 2017–2024 (USD Million)
Table 9 Ultrasound Imaging Market, By Region, 2017–2024 (USD Million)
Table 10 Ultrasound Imaging Market, By Country, 2017–2024 (USD Million)
Table 11 Computed Tomography Market, By Region, 2017–2024 (USD Million)
Table 12 Computed Tomography Market, By Country, 2017–2024 (USD Million)
Table 13 X-Ray Lymphography Market, By Region, 2017–2024 (USD Million)
Table 14 X-Ray Lymphography Market, By Country, 2017–2024 (USD Million)
Table 15 Bioimpedance Analysis Market, By Region, 2017–2024 (USD Million)
Table 16 Bioimpedance Analysis Market, By Country, 2017–2024 (USD Million)
Table 17 Near-Infrared Fluorescence Imaging Market, By Type, 2017–2024 (USD Million)
Table 18 Near-Infrared Fluorescence Imaging Market, By Region, 2017–2024 (USD Million)
Table 19 Near-Infrared Fluorescence Imaging Market, By Country, 2017–2024 (USD Million)
Table 20 ICG Lymphography Market, By Region, 2017–2024 (USD Million)
Table 21 ICG Lymphography Market, By Country, 2017–2024 (USD Million)
Table 22 Fluorescein Sodium Microlymphangiography Market, By Region, 2017–2024 (USD Million)
Table 23 Fluorescein Sodium Microlymphangiography Market, By Country, 2017–2024 (USD Million)
Table 24 Lymphedema Diagnostics Market, By Disease Type, 2017–2024 (USD Million)
Table 25 Market for Cancer, By Region, 2017–2024 (USD Million)
Table 26 Market for Inflammatory Diseases, By Region, 2017–2024 (USD Million)
Table 27 Market for Cardiovascular Disease, By Region, 2017–2024 (USD Million)
Table 28 Market for Other Diseases, By Region, 2017–2024 (USD Million)
Table 29 Market, By End User, 2017–2024 (USD Million)
Table 30 Market for Hospitals, By Region, 2017–2024 (USD Million)
Table 31 Market for Diagnostic Centers, By Region, 2017–2024 (USD Million)
Table 32 Lymphedema Diagnostics Market for Research & Academic Institutes, By Region, 2017–2024 (USD Million)
Table 33 Market for Other End Users, By Region, 2017–2024 (USD Million)
Table 34 Market, By Region, 2017–2024 (USD Million)
Table 35 Market, By Country, 2017–2024 (USD Million)
Table 36 North America: Market, By Country, 2017–2024 (USD Million)
Table 37 North America: Market, By Technology, 2017–2024 (USD Million)
Table 38 North America: Market for Near-Infrared Fluorescence Imaging, By Type, 2017–2024 (USD Million)
Table 39 North America: Market, By Disease Type, 2017–2024 (USD Million)
Table 40 North America: Market, By End User, 2017–2024 (USD Million)
Table 41 US: Market, By Technology, 2017–2024 (USD Million)
Table 42 US: Market for Near-Infrared Fluorescence Imaging, By Type, 2017–2024 (USD Million)
Table 43 US: Market, By Disease Type, 2017–2024 (USD Million)
Table 44 US: Market, By End User, 2017–2024 (USD Million)
Table 45 Canada: Market, By Technology, 2017–2024 (USD Million)
Table 46 Canada: Lymphedema Diagnostics Market for Near-Infrared Fluorescence Imaging, By Type, 2017–2024 (USD Million)
Table 47 Canada: Market, By Disease Type, 2017–2024 (USD Million)
Table 48 Canada: Market, By End User, 2017–2024 (USD Million)
Table 49 Europe: Market, By Country, 2017–2024 (USD Million)
Table 50 Europe: Market, By Technology, 2017–2024 (USD Million)
Table 51 Europe: Market for Near-Infrared Fluorescence Imaging, By Type, 2017–2024 (USD Million)
Table 52 Europe: Market, By Disease Type, 2017–2024 (USD Million)
Table 53 Europe: Market, By End User, 2017–2024 (USD Million)
Table 54 Germany: Market, By Technology, 2017–2024 (USD Million)
Table 55 Germany: Market for Near-Infrared Fluorescence Imaging, By Type, 2017–2024 (USD Million)
Table 56 Germany: Market, By Disease Type, 2017–2024 (USD Million)
Table 57 Germany: Market, By End User, 2017–2024 (USD Million)
Table 58 France: Lymphedema Diagnostics Market, By Technology, 2017–2024 (USD Million)
Table 59 France: Market for Near-Infrared Fluorescence Imaging, By Type, 2017–2024 (USD Million)
Table 60 France: Market, By Disease Type, 2017–2024 (USD Million)
Table 61 France: Market, By End User, 2017–2024 (USD Million)
Table 62 UK: Market, By Technology, 2017–2024 (USD Million)
Table 63 UK: Market for Near-Infrared Fluorescence Imaging, By Type, 2017–2024 (USD Million)
Table 64 UK: Market, By Disease Type, 2017–2024 (USD Million)
Table 65 UK: Market, By End User, 2017–2024 (USD Million)
Table 66 RoE: Market, By Technology, 2017–2024 (USD Million)
Table 67 RoE: Market for Near-Infrared Fluorescence Imaging, By Type, 2017–2024 (USD Million)
Table 68 RoE: Lymphedema Diagnostics Market, By Disease Type, 2017–2024 (USD Million)
Table 69 RoE: Market, By End User, 2017–2024 (USD Million)
Table 70 Asia Pacific: Market, By Country, 2017–2024 (USD Million)
Table 71 Asia Pacific: Market, By Technology, 2017–2024 (USD Million)
Table 72 Asia Pacific: Market for Near-Infrared Fluorescence Imaging, By Type, 2017–2024 (USD Million)
Table 73 Asia Pacific: Market, By Disease Type, 2017–2024 (USD Million)
Table 74 Asia Pacific: Market, By End User, 2017–2024 (USD Million)
Table 75 China: Market, By Technology, 2017–2024 (USD Million)
Table 76 China: Market for Near-Infrared Fluorescence Imaging, By Type, 2017–2024 (USD Million)
Table 77 China: Market, By Disease Type, 2017–2024 (USD Million)
Table 78 China: Market, By End User, 2017–2024 (USD Million)
Table 79 Japan: Market, By Technology, 2017–2024 (USD Million)
Table 80 Japan: Market for Near-Infrared Fluorescence Imaging, By Type, 2017–2024 (USD Million)
Table 81 Japan: Lymphedema Diagnostics Market, By Disease Type, 2017–2024 (USD Million)
Table 82 Japan: Market, By End User, 2017–2024 (USD Million)
Table 83 India: Market, By Technology, 2017–2024 (USD Million)
Table 84 India: Market for Near-Infrared Fluorescence Imaging, By Type, 2017–2024 (USD Million)
Table 85 India: Market, By Disease Type, 2017–2024 (USD Million)
Table 86 India: Market, By End User, 2017–2024 (USD Million)
Table 87 RoAPAC: Market, By Technology, 2017–2024 (USD Million)
Table 88 RoAPAC: Lymphedema Diagnostics Market for Near-Infrared Fluorescence Imaging, By Type, 2017–2024 (USD Million)
Table 89 RoAPAC: Market, By Disease Type, 2017–2024 (USD Million)
Table 90 RoAPAC: Market, By End User, 2017–2024 (USD Million)
Table 91 RoW: Market, By Region, 2017–2024 (USD Million)
Table 92 RoW: Market, By Technology, 2017–2024 (USD Million)
Table 93 RoW: Market for Near-Infrared Fluorescence Imaging, By Type, 2017–2024 (USD Million)
Table 94 RoW: Market, By Disease Type, 2017–2024 (USD Million)
Table 95 RoW: Market, By End User, 2017–2024 (USD Million)
Table 96 Latin America: Lymphedema Diagnostics Market, By Technology, 2017–2024 (USD Million)
Table 97 Latin America: Market for Near-Infrared Fluorescence Imaging, By Type, 2017–2024 (USD Million)
Table 98 Latin America: Market, By Disease Type, 2017–2024 (USD Million)
Table 99 Latin America: Market, By End User, 2017–2024 (USD Million)
Table 100 Middle East & Africa: Market, By Technology, 2017–2024 (USD Million)
Table 101 Middle East & Africa: Market for Near-Infrared Fluorescence Imaging, By Type, 2017–2024 (USD Million)
Table 102 Middle East & Africa: Market, By Disease Type, 2017–2024 (USD Million)
Table 103 Middle East & Africa: Market, By End User, 2017–2024 (USD Million)
Table 104 Product Launches, Enhancements, & Approvals
Table 105 Partnerships, Collaborations, & Agreements
Table 106 Acquisitions
Table 107 Expansions

List of Figures (30 Figures)
Figure 1 Lymphedema Diagnostics Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Primaries: Global Market
Figure 4 Research Methodology: Hypothesis Building
Figure 5 Market Size Estimation: Market
Figure 6 Data Triangulation Methodology
Figure 7 Market, By Technology, 2019 vs 2024 (USD Million)
Figure 8 Geographic Analysis: Lymphedema Diagnostics Market, By Disease Type, 2019
Figure 9 Market, By End User, 2019 vs 2024
Figure 10 Geographical Snapshot of the Market
Figure 11 Rising Prevalence of Lymphedema—A Major Factor Driving the Market for Lymphedema Diagnostics
Figure 12 North America to Account for the Largest Share of the Lymphedema Diagnostics Market, By Disease Type, in 2019
Figure 13 Near-Infrared Fluorescence Imaging to Register the Highest Growth in the Market During the Forecast Period
Figure 14 ICG Lymphography Segment Will Continue to Dominate the Near-Infrared Fluorescence Imaging Market in 2024
Figure 15 China to Register the Highest Growth During the Forecast Period
Figure 16 Lymphedema Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 North America: Market Snapshot
Figure 18 Europe: Market Snapshot
Figure 19 Asia Pacific: Market Snapshot
Figure 20 GE Healthcare Held the Leading Position in the Market in 2018
Figure 21 Market (Global) Competitive Leadership Mapping, 2018
Figure 22 GE Healthcare: Company Snapshot
Figure 23 Siemens AG: Company Snapshot
Figure 24 Philips: Company Snapshot
Figure 25 Canon, Inc.: Company Snapshot
Figure 26 Shimadzu Corporation: Company Snapshot
Figure 27 Stryker Corporation: Company Snapshot
Figure 28 Hitachi, Ltd.: Company Snapshot
Figure 29 Neusoft Corporation: Company Snapshot
Figure 30 Impedimed Limited: Company Snapshot

★調査レポート[リンパ浮腫診断の世界市場予測:リンシンシングラフィ、MRI、近赤外蛍光イメージング、超音波] ( Lymphedema Diagnostics Market by Technology (Lymphoscintigraphy, MRI, Near IR Fluorescence Imaging, Ultrasound), Disease Type (Cancer, Inflammatory Diseases, Cardiovascular, Filariasis), End User (Hospitals, Diagnostic Centers) - Global Forecasts to 2024 / MD7408) 販売に関する免責事項
[リンパ浮腫診断の世界市場予測:リンシンシングラフィ、MRI、近赤外蛍光イメージング、超音波] ( Lymphedema Diagnostics Market by Technology (Lymphoscintigraphy, MRI, Near IR Fluorescence Imaging, Ultrasound), Disease Type (Cancer, Inflammatory Diseases, Cardiovascular, Filariasis), End User (Hospitals, Diagnostic Centers) - Global Forecasts to 2024 / MD7408) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆